These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12706647)

  • 1. Are PNAs a match for the BBB?
    Habeck M
    Drug Discov Today; 2003 May; 8(9):377-8. PubMed ID: 12706647
    [No Abstract]   [Full Text] [Related]  

  • 2. Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression.
    Tyler BM; Jansen K; McCormick DJ; Douglas CL; Boules M; Stewart JA; Zhao L; Lacy B; Cusack B; Fauq A; Richelson E
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7053-8. PubMed ID: 10359837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligonucleotides for target validation in the CNS.
    Ho SP; Hartig PR
    Curr Opin Mol Ther; 1999 Jun; 1(3):336-43. PubMed ID: 11713799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration.
    McMahon BM; Mays D; Lipsky J; Stewart JA; Fauq A; Richelson E
    Antisense Nucleic Acid Drug Dev; 2002 Apr; 12(2):65-70. PubMed ID: 12074366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PNAs breach the blood-brain barrier?
    During MJ; Janson CG
    Nat Biotechnol; 1999 Aug; 17(8):753-4. PubMed ID: 10429237
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting Cancer Gene Dependencies with Anthrax-Mediated Delivery of Peptide Nucleic Acids.
    Lu Z; Paolella BR; Truex NL; Loftis AR; Liao X; Rabideau AE; Brown MS; Busanovich J; Beroukhim R; Pentelute BL
    ACS Chem Biol; 2020 Jun; 15(6):1358-1369. PubMed ID: 32348107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal injection of antisense peptide nucleic acids targeted to the mu receptor decreases response to morphine and receptor protein levels in rat brain.
    McMahon BM; Stewart JA; Jackson J; Fauq A; McCormick DJ; Richelson E
    Brain Res; 2001 Jun; 904(2):345-9. PubMed ID: 11406133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin: peptide for the next millennium.
    Tyler-McMahon BM; Boules M; Richelson E
    Regul Pept; 2000 Sep; 93(1-3):125-36. PubMed ID: 11033059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions.
    Rostene W; Azzi M; Boudin H; Lepee I; Souaze F; Mendez-Ubach M; Betancur C; Gully D
    Ann N Y Acad Sci; 1997 Apr; 814():125-41. PubMed ID: 9160965
    [No Abstract]   [Full Text] [Related]  

  • 10. Antisense properties of peptide nucleic acid.
    Larsen HJ; Bentin T; Nielsen PE
    Biochim Biophys Acta; 1999 Dec; 1489(1):159-66. PubMed ID: 10807005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of Naked Peptide Nucleic Acids into Liposomes Leads to Fast and Efficient Delivery.
    Avitabile C; Accardo A; Ringhieri P; Morelli G; Saviano M; Montagner G; Fabbri E; Gallerani E; Gambari R; Romanelli A
    Bioconjug Chem; 2015 Aug; 26(8):1533-41. PubMed ID: 26176882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular delivery of peptide nucleic acid by cell-penetrating peptides.
    Kilk K; Langel U
    Methods Mol Biol; 2005; 298():131-41. PubMed ID: 16044544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of peptide nucleic acids in tissue extracts of treated animals by gel mobility shift assay.
    Jansen K; Richelson E
    J Biochem Biophys Methods; 2000 Jan; 42(1-2):31-4. PubMed ID: 10647812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide nucleic acids (PNAs) antisense effect to bacterial growth and their application potentiality in biotechnology.
    Hatamoto M; Ohashi A; Imachi H
    Appl Microbiol Biotechnol; 2010 Mar; 86(2):397-402. PubMed ID: 20135118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides.
    Shiraishi T; Pankratova S; Nielsen PE
    Chem Biol; 2005 Aug; 12(8):923-9. PubMed ID: 16125104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear localization and antisense effect of PNA internalized by ASGP-R-mediated endocytosis with protein/DNA conjugates.
    Ishihara T; Kano A; Obara K; Saito M; Chen X; Park TG; Akaike T; Maruyama A
    J Control Release; 2011 Oct; 155(1):34-9. PubMed ID: 20955741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin and neurotensin receptors.
    Vincent JP; Mazella J; Kitabgi P
    Trends Pharmacol Sci; 1999 Jul; 20(7):302-9. PubMed ID: 10390649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense peptide nucleic acid-mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice.
    Turner BJ; Cheah IK; Macfarlane KJ; Lopes EC; Petratos S; Langford SJ; Cheema SS
    J Neurochem; 2003 Nov; 87(3):752-63. PubMed ID: 14535957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense inhibition of delta-opioid receptor gene function in vivo by peptide nucleic acids.
    Fraser GL; Holmgren J; Clarke PB; Wahlestedt C
    Mol Pharmacol; 2000 Apr; 57(4):725-31. PubMed ID: 10727518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide nucleic acids specifically cause antigene effects in vivo by systemic injection.
    McMahon BM; Stewart JA; Bitner MD; Fauq A; McCormick DJ; Richelson E
    Life Sci; 2002 Jun; 71(3):325-37. PubMed ID: 12034350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.